IFNG and neoplasm: However, some studies suggest that this immune checkpoint may become important post-NK therapy infusion because expanded NK cells increase PD-1 expression in the presence of tumor cells, and IFN-γ produced by NK cells augments PD-L1 expression in a lung cancer mouse model (198).